Galderma Investigational Site

Lublin 20-081

0 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Prurigo Nodularis

Studies at this site

• A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) — Completed
• Dose-ranging Study of Nemolizumab in Atopic Dermatitis — Completed